Justin J. Noznesky, Chief Marketing & Strategy Officer at AtriCure, Inc. (ATRC), sold 1,500 shares at $36.72 ($55K) on 2024-03-12, disclosed to the SEC on 2024-03-14.
Scheduled sale ($55k) by Chief Marketing & Strategy Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2025-09-16 | $218K | — | Filing → |
| ATRC | SELL | 2024-05-03 | $36K | — | Filing → |
| ATRC | SELL | 2024-04-03 | $46K | — | Filing → |